 | Up a level |
Kovanda, Laura L 
ORCID: 0000-0002-4493-4652, Marty, Francisco M, Maertens, Johan, Desai, Amit V, Lademacher, Christopher, Engelhardt, Marc, Lu, Qiaoyang and Hope, William W ORCID: 0000-0001-6187-878X
(2017)
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (6).
e00101-e00117.
Kontoyiannis, Dimitrios P, Selleslag, Dominik, Mullane, Kathleen, Cornely, Oliver A, Hope, William ORCID: 0000-0001-6187-878X, Lortholary, Olivier, Croos-Dabrera, Rodney, Lademacher, Christopher, Engelhardt, Marc and Patterson, Thomas F
(2018)
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a <i>post hoc</i> analysis of the SECURE trial.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 73 (3).
pp. 757-763.
Andes, David R, Ghannoum, Mahmoud A, Mukherjee, Pranab K, Kovanda, Laura L ORCID: 0000-0002-4493-4652, Lu, Qiaoyang, Jones, Mark E, Henriksen, Anne Santerre, Lademacher, Christopher and Hope, William W ORCID: 0000-0001-6187-878X
(2019)
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (1).
e01634-e01618.
Benjamin, Daniel K Jr, Kaufman, David A, Hope, William W ORCID: 0000-0001-6187-878X, Smith, P Brian, Arrieta, Antonio, Manzoni, Paolo, Kovanda, Laura L, Lademacher, Christopher, Isaacson, Brigit, Jednachowski, Deborah et al (show 3 more authors)
(2018)
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 37 (10).
pp. 992-998.